From the Department of Anesthesiology, 180th Hospital of PLA, Quanzhou, China (BZ, ZW, PX, HX, LX) and Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA (HW).
Eur J Anaesthesiol. 2021 Mar 1;38(3):294-301. doi: 10.1097/EJA.0000000000001401.
Hypoxaemia is frequently seen during flexible bronchoscopies that are done with a nasal approach under the traditional sedation with propofol. This study investigated the potential benefits of supraglottic jet oxygenation and ventilation (SJOV) using the Wei nasal jet tube (WNJ) in reducing hypoxaemia in patients undergoing bronchoscopy under moderate to deep intravenous sedation using a propofol, lidocaine and remifentanil cocktail.
Our primary objective was to evaluate the efficacy and complications of SJOV via the WNJ during flexible bronchoscopy under moderate to heavy sedation with propofol and remifentanil.
A randomised controlled clinical trial.
The 180th Hospital of People's Liberation Army, Quanzhou, China, from 1 June to 1 November 2019.
A total of 280 patients aged ≥18 years with American Society of Anesthesiologists' physical status 1 to 3 undergoing flexible bronchoscopy were studied.
Patients were assigned randomly into one of two groups, a nasal cannula oxygenation (NCO) group (n = 140) using a nasal cannula to deliver oxygen (4 l min-1) or the SJOV group (n = 140) using a WNJ connected to a manual jet ventilator to provide SJOV at a driving pressure of 103 kPa, respiratory rate 20 min-1, FiO2 1.0 and inspiratory:expiratory (I:E) ratio 1:2.
The primary outcome was an incidence of desaturation (defined as SpO2 < 90%) during the procedure. Other adverse events related to the sedation or SJOV were also recorded.
Compared with the NCO group, the incidence of desaturation in the SJOV group was lower (NCO 37.0% vs. SJOV 13.1%) (P < 0.001). Patients in the SJOV group had a higher incidence of a dry mouth at 1 min (13.1% vs. 1.5%, P < 0.001) than at 30 min (1.5% vs. 0%, P = 0.159) or at 24 h (0% vs. 0%). There was no significant difference between the groups in respect of sore throat, subcutaneous emphysema or nasal bleeding.
SJOV via a WNJ during flexible bronchoscopy under moderate to deep sedation with propofol and remifentanil significantly reduces the incidence of desaturation when compared with regular oxygen supplementation via a nasal cannula. Patients in the SJOV group had an increased incidence of transient dry mouth.
Registered at www.chictr.org.cn (ChiCTR1900023514).
在经鼻入路行纤维支气管镜检查时,常出现低氧血症,而传统的异丙酚镇静下进行该操作时更容易出现这种情况。本研究旨在探讨在异丙酚、利多卡因和瑞芬太尼鸡尾酒静脉镇静下,使用魏氏鼻咽喷射管(WNJ)行经鼻喷射氧合通气(SJOV)对减少中度至深度镇静下纤维支气管镜检查患者低氧血症的潜在益处。
本研究的主要目的是评估 SJOV 在异丙酚和瑞芬太尼中度至重度镇静下经鼻纤维支气管镜检查中的疗效和并发症。
随机对照临床试验。
中国解放军第 180 医院,泉州,2019 年 6 月 1 日至 11 月 1 日。
280 例年龄≥18 岁、美国麻醉医师协会身体状况 1-3 级、拟行纤维支气管镜检查的患者。
患者随机分为两组,一组使用鼻导管吸氧(NCO)组(n=140),给予 4 l/min 的氧气;另一组使用 WNJ 组(n=140),通过连接到手动喷射通气机的 WNJ 提供 SJOV,驱动压力为 103 kPa,呼吸频率 20 min-1,FiO2 为 1.0,吸气:呼气(I:E)比值为 1:2。
主要结局是术中发生低氧血症(定义为 SpO2<90%)的发生率。还记录了与镇静或 SJOV 相关的其他不良事件。
与 NCO 组相比,SJOV 组的低氧血症发生率较低(NCO 组 37.0% vs. SJOV 组 13.1%)(P<0.001)。SJOV 组在 1 分钟(13.1%)时口干的发生率高于 30 分钟(1.5%)(P<0.001)和 24 小时(0%)(P=0.159)。两组间咽痛、皮下气肿或鼻出血发生率无显著差异。
与常规经鼻导管补充氧气相比,在异丙酚和瑞芬太尼中度至深度镇静下经鼻纤维支气管镜检查时,使用 WNJ 行 SJOV 可显著降低低氧血症的发生率。SJOV 组患者出现一过性口干的发生率增加。
在中国临床试验注册中心注册(ChiCTR1900023514)。